Companies within the dechra group
Pharmaceutical Division
Our Pharmaceutical Division comprises Dechra Veterinary Products (“DVP EU”), Dechra Veterinary Products USA (“DVP USA”) and Dales Pharmaceuticals (“Dales”).
DVP EU
Dechra Veterinary Products EU (DVP-EU), located in Shrewsbury, England and in Uldum, Denmark, employs 212 people. |
 |
The VetXX and Arnolds Veterinary Products brands and products are now fully incorporated in to the DVP-EU companion animal portfolio. |
Dechra Veterinary Products EU Management Team |
The company is focussed on providing therapeutic solutions for the care of companion animals. The key areas of expertise span dermatology, endocrinology, equine medicine, ophthalmology and critical care. The leading branded pharmaceuticals for companion animals include Vetoryl® Capsules, for the treatment of canine hyperadrenocorticism (Cushing's syndrome); Felimazole® Tablets, for treating feline hyperthyroidism and Equipalazone® the market-leading non-steroidal anti-inflammatory for equine musculoskeletal disorders. The recent additions of the SPECIFIC® dog and cat diet range, the ophthalmic product Fucithalmic® Vet and the dermatology brands Canaural®, Fuciderm® Gel and Malaseb® Shampoo further strengthen Dechra's product portfolio. There is a strong emphasis on product development with an ongoing programme of investment that will further enhance our product offering to veterinarians across Europe.
Dechra Veterinary Products UK Management Team |
|||
 |
 |
 |
 |
Bob Parmenter |
Gwenda Bason |
Mark Sallin |
Chris Kingdon |
Visit Dechra Veterinary Products EU Website
DVP US
Dechra Veterinary Products US (DVP US) was established in 2005 and is located in Overland Park, Kansas. DVP US employs 16 people and is currently expanding its technical services and sales and marketing personnel. In December 2008, Dechra Pharmaceuticals PLC received FDA approval to market Vetoryl® Capsules in the US. Dechra is also at an advanced stage of development of other products for the US market including Felimazole® and Equidone®. DVP US currently markets a line of veterinary approved dermatologic, otic and ophthalmic products, as well as a specialised equine lameness product. Dechra distributes its products through the existing network of veterinary suppliers throughout the USA, who also provide first line sales support.
Visit Dechra Veterinary Products US Website
Dales
Dales, located in Skipton, England, employing 129 people is a fully Medicines and Healthcare Regulatory Agency (“MHRA”) approved pharmaceutical manufacturer with multi-competence in both scale and dose form. Dales manufactures the vast majority of our own branded licensed pharmaceutical products, which are marketed through DVP, but also derive approximately 50% of revenues from third party toll manufacture, predominantly for human pharmaceutical companies. This is Dechra’s only significant source of revenue not derived from the veterinary market.
Services Division
Our Services Division comprises of National Veterinary Services (“NVS®”), NationWide Laboratories (“NWL”) and Cambridge Specialist Laboratory Services (“CSLS”).
NVS
NVS®, located in Stoke-on-Trent, England, employing 453 people, is the UK market leader, as measured in terms of market share, in the supply and distribution of veterinary products to veterinary practices and other approved outlets.
NVS stock a range of over 12,000 products including pharmaceuticals, pet products, consumables and accessories. NVS has also developed a range of IT solutions for veterinary practices which are branded “Vetcom®”. Vetcom’s principle objective is to collect orders electronically. Approximately 80% of NVS’s orders arrive automatically with no human input required. NVS distributes to 1,500 customers daily utilising its own fleet of vans and Heavy Goods Vehicles (“HGVs”). The 
centralised stock located in Stoke-on-Trent is picked and packed throughout the afternoon and evening and then distributed overnight to trunking depots by the HGVs on large trailers. Van drivers are then employed locally at these depots who distribute the goods to the customers. NVS operates on a Sunday until Thursday shift which allows customers to place orders up until 7.30 p.m. Monday to Thursday and any time over the weekend up to 11.00 a.m. on Sunday for a next working day delivery.
NVS services companion animal practices, livestock practices and agricultural merchants, with sales being approximately 60% in favour of companion animal related products.
Laboratories
NWL is located in Poulton-le-Fylde, England and employs 44 people. It is a first referral veterinary laboratory, providing histology, pathology, haematology, chemistry and microbiology services to veterinary practices. Whilst a certain amount of simple chemistry is performed at veterinary practices, nearly all veterinary practices will outsource more advanced analytical tests, often requiring expert interpretation of results. We consider NWL to offer the highest level of service within this sector. We were the first veterinary laboratory to gain UKAS (United Kingdom Accreditation Service) approval. NWL also offers other services such as Allervet, a pet and equine allergy testing programme and Petscreen, a chemotherapy sensitivity test for small animal tumours.
NWL Management Team |
||
 |
 |
 |
Peter Graham |
Mark Davies |
Jamie Whitwam |
CSLS, located in Sawston, England employs 6 people. It operates as a first and second referral laboratory, with its key area of expertise being endocrinology. The second referral work, i.e. providing services for NWL and some of NWL’s competitors, is mainly derived from specialisation in radio-immuno assays. The business also provides precise assays which support the dosage regimes and patient monitoring of our key products, Vetoryl® Capsules and Felimazole® Tablets.